First Page
211
Recommended Citation
Yaniv
Heled
Why Primary Patents Covering Biologics Should Be Unforceable against Generic Applicants under the Biologics Price Competition and Innovation Act,
21
Annals Health L.
211
(2012).
Available at: https://lawecommons.luc.edu/annals/vol21/iss1/20